Fluid Overload in Pediatric Univentricular Patients Undergoing Fontan Completion

Victorien A C Luppes1, Ariane Willems2, Mark G Hazekamp3

  • 1Department of Pediatric Cardiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Insights

Fluid overload (FO) in Fontan completion patients significantly increases pediatric intensive care unit (PICU) length of stay and the risk of cardiac events. Managing FO is crucial for better outcomes in these vulnerable children.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Fluid Balance Management

Background:

  • Fluid overload (FO) is a common complication post-pediatric cardiac surgery, linked to increased morbidity and mortality.
  • Fontan patients face a high risk of FO due to delicate fluid balance requirements and the need for adequate preload.
  • Understanding FO's impact is critical for optimizing care in this high-risk population.

Purpose of the Study:

  • To identify the presence of fluid overload (FO) in children undergoing Fontan completion.
  • To evaluate the impact of FO on pediatric intensive care unit (PICU) length of stay (LOS).
  • To assess the association between FO and cardiac events, including mortality, re-surgery, and re-hospitalization.

Main Methods:

  • Retrospective, single-center study design.
  • Inclusion of 43 consecutive pediatric patients undergoing Fontan completion.
  • Assessment of fluid overload (FO) presence and quantification.

Main Results:

  • Patients with >5% maximum FO experienced significantly longer PICU LOS (3.9 vs. 1.9 days) and mechanical ventilation duration (21 vs. 6 hours).
  • A 1% increase in maximum FO correlated with a 13% increase in PICU LOS.
  • Fluid overload (FO) was associated with a higher risk of adverse cardiac events.

Conclusions:

  • Fluid overload (FO) is linked to both short-term (PICU LOS, ventilation) and long-term (cardiac events) complications in Fontan completion patients.
  • Further research is necessary to fully elucidate the impact of FO on outcomes in this specific pediatric population.
  • Early identification and management of FO may be crucial for improving patient outcomes.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
19
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
34
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
52
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
20
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
43